Copyright Reports & Markets. All rights reserved.

Global Dengue Rapid Test Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Dengue Rapid Test by Type
    • 1.3.1 Overview: Global Dengue Rapid Test Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Dengue Rapid Test Consumption Value Market Share by Type in 2025
    • 1.3.3 NS1 Antigen Detection
    • 1.3.4 IgM Antibody Detection
    • 1.3.5 IgG Antibody Detection
    • 1.3.6 Others
  • 1.4 Classification of Dengue Rapid Test by Technical Principles
    • 1.4.1 Overview: Global Dengue Rapid Test Market Size by Technical Principles: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global Dengue Rapid Test Consumption Value Market Share by Technical Principles in 2025
    • 1.4.3 Colloidal Gold Immunochromatography
    • 1.4.4 ELISA
    • 1.4.5 Latex Agglutination
    • 1.4.6 Others
  • 1.5 Classification of Dengue Rapid Test by Product Form
    • 1.5.1 Overview: Global Dengue Rapid Test Market Size by Product Form: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global Dengue Rapid Test Consumption Value Market Share by Product Form in 2025
    • 1.5.3 Test Cards
    • 1.5.4 Test Strips
    • 1.5.5 Microplates
    • 1.5.6 Others
  • 1.6 Global Dengue Rapid Test Market by Application
    • 1.6.1 Overview: Global Dengue Rapid Test Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Healthcare Industry
    • 1.6.3 Public Health Sector
    • 1.6.4 Others
  • 1.7 Global Dengue Rapid Test Market Size & Forecast
  • 1.8 Global Dengue Rapid Test Market Size and Forecast by Region
    • 1.8.1 Global Dengue Rapid Test Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global Dengue Rapid Test Market Size by Region, (2021-2032)
    • 1.8.3 North America Dengue Rapid Test Market Size and Prospect (2021-2032)
    • 1.8.4 Europe Dengue Rapid Test Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific Dengue Rapid Test Market Size and Prospect (2021-2032)
    • 1.8.6 South America Dengue Rapid Test Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa Dengue Rapid Test Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Dengue Rapid Test Product and Solutions
    • 2.1.4 Abbott Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Recent Developments and Future Plans
  • 2.2 SD Biosensor
    • 2.2.1 SD Biosensor Details
    • 2.2.2 SD Biosensor Major Business
    • 2.2.3 SD Biosensor Dengue Rapid Test Product and Solutions
    • 2.2.4 SD Biosensor Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 SD Biosensor Recent Developments and Future Plans
  • 2.3 bioMérieux
    • 2.3.1 bioMérieux Details
    • 2.3.2 bioMérieux Major Business
    • 2.3.3 bioMérieux Dengue Rapid Test Product and Solutions
    • 2.3.4 bioMérieux Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 bioMérieux Recent Developments and Future Plans
  • 2.4 CTK Biotech
    • 2.4.1 CTK Biotech Details
    • 2.4.2 CTK Biotech Major Business
    • 2.4.3 CTK Biotech Dengue Rapid Test Product and Solutions
    • 2.4.4 CTK Biotech Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 CTK Biotech Recent Developments and Future Plans
  • 2.5 Wondfo
    • 2.5.1 Wondfo Details
    • 2.5.2 Wondfo Major Business
    • 2.5.3 Wondfo Dengue Rapid Test Product and Solutions
    • 2.5.4 Wondfo Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Wondfo Recent Developments and Future Plans
  • 2.6 Roche Diagnostics
    • 2.6.1 Roche Diagnostics Details
    • 2.6.2 Roche Diagnostics Major Business
    • 2.6.3 Roche Diagnostics Dengue Rapid Test Product and Solutions
    • 2.6.4 Roche Diagnostics Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Roche Diagnostics Recent Developments and Future Plans
  • 2.7 ACON Biotech
    • 2.7.1 ACON Biotech Details
    • 2.7.2 ACON Biotech Major Business
    • 2.7.3 ACON Biotech Dengue Rapid Test Product and Solutions
    • 2.7.4 ACON Biotech Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 ACON Biotech Recent Developments and Future Plans
  • 2.8 InBios International
    • 2.8.1 InBios International Details
    • 2.8.2 InBios International Major Business
    • 2.8.3 InBios International Dengue Rapid Test Product and Solutions
    • 2.8.4 InBios International Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 InBios International Recent Developments and Future Plans
  • 2.9 CTK Biotech
    • 2.9.1 CTK Biotech Details
    • 2.9.2 CTK Biotech Major Business
    • 2.9.3 CTK Biotech Dengue Rapid Test Product and Solutions
    • 2.9.4 CTK Biotech Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 CTK Biotech Recent Developments and Future Plans
  • 2.10 Bio-Rad Laboratories
    • 2.10.1 Bio-Rad Laboratories Details
    • 2.10.2 Bio-Rad Laboratories Major Business
    • 2.10.3 Bio-Rad Laboratories Dengue Rapid Test Product and Solutions
    • 2.10.4 Bio-Rad Laboratories Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.11 DiaSorin Group
    • 2.11.1 DiaSorin Group Details
    • 2.11.2 DiaSorin Group Major Business
    • 2.11.3 DiaSorin Group Dengue Rapid Test Product and Solutions
    • 2.11.4 DiaSorin Group Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 DiaSorin Group Recent Developments and Future Plans
  • 2.12 Siemens Healthineers
    • 2.12.1 Siemens Healthineers Details
    • 2.12.2 Siemens Healthineers Major Business
    • 2.12.3 Siemens Healthineers Dengue Rapid Test Product and Solutions
    • 2.12.4 Siemens Healthineers Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Siemens Healthineers Recent Developments and Future Plans
  • 2.13 Thermo Fisher Scientific
    • 2.13.1 Thermo Fisher Scientific Details
    • 2.13.2 Thermo Fisher Scientific Major Business
    • 2.13.3 Thermo Fisher Scientific Dengue Rapid Test Product and Solutions
    • 2.13.4 Thermo Fisher Scientific Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.14 Reszon Diagnostics International
    • 2.14.1 Reszon Diagnostics International Details
    • 2.14.2 Reszon Diagnostics International Major Business
    • 2.14.3 Reszon Diagnostics International Dengue Rapid Test Product and Solutions
    • 2.14.4 Reszon Diagnostics International Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Reszon Diagnostics International Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Dengue Rapid Test Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Dengue Rapid Test by Company Revenue
    • 3.2.2 Top 3 Dengue Rapid Test Players Market Share in 2025
    • 3.2.3 Top 6 Dengue Rapid Test Players Market Share in 2025
  • 3.3 Dengue Rapid Test Market: Overall Company Footprint Analysis
    • 3.3.1 Dengue Rapid Test Market: Region Footprint
    • 3.3.2 Dengue Rapid Test Market: Company Product Type Footprint
    • 3.3.3 Dengue Rapid Test Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Dengue Rapid Test Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Dengue Rapid Test Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Dengue Rapid Test Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Dengue Rapid Test Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Dengue Rapid Test Consumption Value by Type (2021-2032)
  • 6.2 North America Dengue Rapid Test Market Size by Application (2021-2032)
  • 6.3 North America Dengue Rapid Test Market Size by Country
    • 6.3.1 North America Dengue Rapid Test Consumption Value by Country (2021-2032)
    • 6.3.2 United States Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Dengue Rapid Test Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Dengue Rapid Test Consumption Value by Type (2021-2032)
  • 7.2 Europe Dengue Rapid Test Consumption Value by Application (2021-2032)
  • 7.3 Europe Dengue Rapid Test Market Size by Country
    • 7.3.1 Europe Dengue Rapid Test Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 7.3.3 France Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Dengue Rapid Test Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Dengue Rapid Test Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Dengue Rapid Test Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Dengue Rapid Test Market Size by Region
    • 8.3.1 Asia-Pacific Dengue Rapid Test Consumption Value by Region (2021-2032)
    • 8.3.2 China Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 8.3.5 India Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Dengue Rapid Test Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Dengue Rapid Test Consumption Value by Type (2021-2032)
  • 9.2 South America Dengue Rapid Test Consumption Value by Application (2021-2032)
  • 9.3 South America Dengue Rapid Test Market Size by Country
    • 9.3.1 South America Dengue Rapid Test Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Dengue Rapid Test Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Dengue Rapid Test Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Dengue Rapid Test Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Dengue Rapid Test Market Size by Country
    • 10.3.1 Middle East & Africa Dengue Rapid Test Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Dengue Rapid Test Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Dengue Rapid Test Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Dengue Rapid Test Market Drivers
  • 11.2 Dengue Rapid Test Market Restraints
  • 11.3 Dengue Rapid Test Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Dengue Rapid Test Industry Chain
  • 12.2 Dengue Rapid Test Upstream Analysis
  • 12.3 Dengue Rapid Test Midstream Analysis
  • 12.4 Dengue Rapid Test Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Dengue Rapid Test market size was valued at US$ 644 million in 2025 and is forecast to a readjusted size of US$ 971 million by 2032 with a CAGR of 6.1% during review period.
    Dengue Rapid Test is an in vitro diagnostic (IVD) product based on immunochromatography or other rapid immunoassay techniques. It is used to detect antigens or antibodies related to the dengue virus in human samples within a short time (usually 15–20 minutes), thereby enabling rapid screening or auxiliary diagnosis of dengue infection.
    Gross Profit Margin Level
    As a typical immunochromatographic point-of-care testing (POCT) in vitro diagnostic product, the dengue fever rapid test generally has a mid-to-high gross profit margin in the IVD industry, but exhibits a clear stratified structure. From a supply chain perspective, relying on external procurement for key upstream raw materials such as monoclonal antibodies, recombinant antigens, and membrane materials can constrain costs, while companies with the ability to independently develop core raw materials can typically significantly improve their gross profit margin. In terms of business models, the OEM/white-label supply model, due to intense price competition and orders primarily based on large-volume bidding, generally has a gross profit margin of approximately 35%–50%; while the own-brand + registration and certification + channel distribution model can achieve a gross profit margin of around 50%–65%; further entry into hospital terminals, government projects, and international organization procurement systems, through brand premium and technological endorsement, can further increase the gross profit margin. In addition, the industry's gross profit margin is also affected by the fluctuations of the pandemic cycle, regional price systems (significant differences between developed and developing countries), and channel levels (direct sales or multi-level distribution). Overall, dengue fever rapid testing is not a "low-end test strip" business, but rather a structurally driven industry where profitability is determined by raw material capabilities, registration capabilities, and distribution channels.
    Industry Drivers
    The core growth of the dengue fever rapid testing industry stems from the dual drivers of "disease spread + early diagnosis." On the one hand, with climate change, accelerated urbanization, and the expansion of mosquito vector distribution, the geographical coverage of dengue fever continues to expand, with an increasing incidence and case size, providing a long-term, rigid foundation for testing demand. On the other hand, healthcare systems are shifting from "confirmatory diagnosis" to "screening diagnosis," especially in tropical and subtropical regions, where primary healthcare institutions and public health systems are increasingly reliant on rapid, low-cost, point-of-care testing (POCT) methods. Simultaneously, the increasing clinical demand for early diagnosis has also driven the widespread adoption of NS1 antigen and antibody combination tests, thereby improving testing coverage. Furthermore, the continued expansion of public health projects led by international organizations and governments (such as epidemic surveillance, emergency stockpiling, and large-scale screening) provides a stable source of demand for the industry. With the added trend of multi-pathogen testing (such as dengue fever + Zika + chikungunya), the industry is upgrading from single testing products to platform-based and combined solutions. Overall, the industry's growth is not driven by short-term epidemics, but rather by a medium- to long-term expansion logic shaped by changes in epidemiology, upgrades to primary healthcare systems, and increased investment in public health.
    This report is a detailed and comprehensive analysis for global Dengue Rapid Test market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Dengue Rapid Test market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Dengue Rapid Test market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Dengue Rapid Test market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Dengue Rapid Test market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Dengue Rapid Test
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Dengue Rapid Test market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, SD Biosensor, bioMérieux, CTK Biotech, Wondfo, Roche Diagnostics, ACON Biotech, InBios International, CTK Biotech, Bio-Rad Laboratories, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Dengue Rapid Test market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    NS1 Antigen Detection
    IgM Antibody Detection
    IgG Antibody Detection
    Others
    Market segment by Technical Principles
    Colloidal Gold Immunochromatography
    ELISA
    Latex Agglutination
    Others
    Market segment by Product Form
    Test Cards
    Test Strips
    Microplates
    Others
    Market segment by Application
    Healthcare Industry
    Public Health Sector
    Others
    Market segment by players, this report covers
    Abbott
    SD Biosensor
    bioMérieux
    CTK Biotech
    Wondfo
    Roche Diagnostics
    ACON Biotech
    InBios International
    CTK Biotech
    Bio-Rad Laboratories
    DiaSorin Group
    Siemens Healthineers
    Thermo Fisher Scientific
    Reszon Diagnostics International
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Dengue Rapid Test product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Dengue Rapid Test, with revenue, gross margin, and global market share of Dengue Rapid Test from 2021 to 2026.
    Chapter 3, the Dengue Rapid Test competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Dengue Rapid Test market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Dengue Rapid Test.
    Chapter 13, to describe Dengue Rapid Test research findings and conclusion.

    Buy now